$0.27
+0.02
(+8.4%)▲
7.37%
Downside
Day's Volatility :10.36%
Upside
3.23%
37.04%
Downside
52 Weeks Volatility :85.97%
Upside
77.72%
Period | China Pharma Holdings Inc | Index (Russel 2000) |
---|---|---|
3 Months | 3.37% | 0.0% |
6 Months | -23.85% | 0.0% |
1 Year | -58.97% | 0.0% |
3 Years | -99.03% | -20.8% |
Market Capitalization | 4.6M |
Book Value | $0.43 |
Earnings Per Share (EPS) | -0.92 |
PEG Ratio | 0.0 |
Wall Street Target Price | 3.0 |
Profit Margin | -70.49% |
Operating Margin TTM | -150.44% |
Return On Assets TTM | -17.54% |
Return On Equity TTM | -74.89% |
Revenue TTM | 6.2M |
Revenue Per Share TTM | 0.63 |
Quarterly Revenue Growth YOY | -15.8% |
Gross Profit TTM | 349.3K |
EBITDA | -1.4M |
Diluted Eps TTM | -0.92 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 1011.11%
Sell
Neutral
Buy
China Pharma Holdings Inc is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
China Pharma Holdings Inc | 38.12% | -23.85% | -58.97% | -99.03% | -97.84% |
Neurocrine Biosciences Inc. | -7.03% | -19.56% | -0.82% | 7.76% | 29.22% |
Haleon Plc Spon Ads | -3.46% | 22.02% | 17.45% | 35.36% | 35.36% |
Zoetis Inc. | -0.89% | 14.69% | 8.84% | -3.97% | 51.56% |
Viatris Inc. | 4.13% | -1.36% | 19.98% | -14.97% | -29.07% |
Catalent, Inc. | 1.17% | 6.91% | 36.82% | -53.5% | 27.06% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
China Pharma Holdings Inc | NA | NA | 0.0 | 0.0 | -0.75 | -0.18 | NA | 0.43 |
Neurocrine Biosciences Inc. | 33.78 | 33.78 | 0.26 | 4.57 | 0.16 | 0.12 | NA | 24.87 |
Haleon Plc Spon Ads | 33.45 | 33.45 | 1.48 | 0.36 | 0.07 | 0.04 | 0.02 | 1.82 |
Zoetis Inc. | 36.79 | 36.79 | 2.63 | 5.82 | 0.49 | 0.14 | 0.01 | 10.94 |
Viatris Inc. | 224.4 | NA | 0.07 | 2.67 | -0.03 | 0.03 | 0.04 | 16.36 |
Catalent, Inc. | 211.02 | NA | 2.9 | 0.2 | -0.25 | 0.0 | NA | 19.91 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
China Pharma Holdings Inc | NA | $4.3M | -97.84% | NA | -70.49% |
Neurocrine Biosciences Inc. | Buy | $11.3B | 29.22% | 33.78 | 16.0% |
Haleon Plc Spon Ads | Buy | $46.9B | 35.36% | 33.45 | 9.66% |
Zoetis Inc. | Buy | $86.1B | 51.56% | 36.79 | 26.29% |
Viatris Inc. | Hold | $13.8B | -29.07% | 224.4 | -4.24% |
Catalent, Inc. | Hold | $11.0B | 27.06% | 211.02 | -23.81% |
Insights on China Pharma Holdings Inc
Revenue is down for the last 3 quarters, 2.14M → 924.94K (in $), with an average decrease of 34.4% per quarter
Netprofit is down for the last 2 quarters, -955.89K → -1.43M (in $), with an average decrease of 50.5% per quarter
In the last 1 year, Catalent, Inc. has given 38.2% return, outperforming this stock by 97.8%
In the last 3 years, China Pharma Holdings Inc has experienced a drawdown of -99.0%, however Neurocrine Biosciences Inc. resisted the overall trend and outperformed by 45.5%
china pharma is a pharmaceuticals company based out of haikou. china pharma representatives, don’t miss out on opportunities to build relationships with members on linkedin. claim your page, write a simple description, and share content to attract followers that can lead to new customers, brand fans, and future employees. go here to get started: http://linkd.in/1dupbvu
Organization | China Pharma Holdings Inc |
Employees | 231 |
CEO | Ms. Zhilin Li |
Industry | Health Technology |
Oportun Financial Corp
$0.27
+8.4%
Ft Skybr Crypt & Dig Econ
$0.27
+8.4%
Cadrenal Therapeutics Inc
$0.27
+8.4%
Yieldmax Snow Option Income Strategy Etf
$0.27
+8.4%
Breakwave Tanker Shipping Etf
$0.27
+8.4%
Ubs Ag Etracs Crude Oil Shares Covered Call Etn
$0.27
+8.4%
Old Market Capital Corp
$0.27
+8.4%
Innovator Equity Managed Floor Etf
$0.27
+8.4%
Tiziana Life Sciences Plc
$0.27
+8.4%